Polymeric Biomaterials Market Report 2026

The polymeric biomaterials market size has grown rapidly in recent years. It will grow from $69.32 billion in 2025 to $81 billion in 2026 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period can be attributed to medical implant demand, growth in surgical procedures, polymer science advancements, hospital infrastructure expansion, healthcare technology adoption.

The polymeric biomaterials market size is expected to see rapid growth in the next few years. It will grow to $141.61 billion in 2030 at a compound annual growth rate (CAGR) of 15%. The growth in the forecast period can be attributed to aging population healthcare needs, regenerative medicine growth, minimally invasive surgeries, personalized medicine development, biodegradable polymer innovation. Major trends in the forecast period include rising adoption in tissue engineering, increasing use in drug delivery systems, expansion of biodegradable implant materials, growing demand for advanced surgical polymers, focus on personalized medical biomaterials.

The growing prevalence of chronic diseases is expected to propel the growth of the polymeric biomaterials market going forward. Chronic diseases refer to long-lasting conditions that generally progress slowly and persist over a long period of time, often for the rest of a person's life. The increasing prevalence of chronic diseases is due to several factors, such as the aging population, lifestyle factors, economic burden, healthcare demand, and public health challenges. Polymeric biomaterials are used in treating chronic diseases by offering innovative solutions that enhance the effectiveness of medical treatments and contribute to the overall quality of life for individuals with chronic conditions. They are also used in the development of various medical devices and implants, including stents, catheters, and joint replacements., which are essential for managing chronic diseases that require surgical intervention. For instance, in September 2023, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, each year there are 41 million deaths worldwide, accounting for 74% of all fatalities attributed to chronic diseases. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2 million from diabetes. Therefore, the growing prevalence of chronic diseases is driving the growth of the polymeric biomaterials market.

Major companies operating in the polymeric biomaterials market are focusing on developing advanced innovations, such as reinforced PEEK 3D printing filaments, to gain a competitive advantage. Reinforced PEEK 3D printing filaments are high-performance polymer biomaterials enhanced with carbon fiber, enabling extrusion-based 3D printing of customized medical implants with superior strength, biocompatibility, and metal-free design. For instance, in October 2023, Evonik Industries AG, a Germany-based specialty chemicals company, introduced VESTAKEEP iC4620 3DF and its 12% carbon-fiber variant VESTAKEEP iC4612 3DF. These filaments provide a high strength-to-weight ratio, allow control over fiber alignment during printing for optimized mechanical performance, and offer full biocompatibility for long-term body-contact implants. These advancements support the growing shift toward patient-specific, 3D-printed implants that can match the performance of traditional metal devices, though manufacturers must address process complexity and maintain strict quality control to ensure consistent mechanical properties.

In July 2023, Biocoat Incorporated, a US-based provider of hydrophilic biomaterial coatings, coating services, and custom polymer solutions for medical devices, acquired Chempilots for an undisclosed amount. Through this acquisition, Biocoat aimed to strengthen its polymer development capabilities and expand its biomaterial product portfolio to support complex medical device applications. Chempilots is a Denmark-based provider of specialty polymers and contract synthesis services, offering advanced polymerization and manufacturing of biocompatible polymers and hydrogels for medical device and biomaterials applications.

Major companies operating in the polymeric biomaterials market are BASF SE, 3M Company, Medtronic plc, Toray Industries Inc., Evonik Industries AG, Covestro AG, Stryker Corporation, Solvay SA, DuPont Biomaterials, Arkema Group, Mitsubishi Chemical Holdings Inc., Celanese Corporation, Royal DSM, TEIJIN Limited, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., W. L. Gore & Associates Inc., Corbion NV, Integra LifeSciences Holdings Corporation, Victrex plc, Collagen Matrix, Berkeley Advanced Biomaterials, Bezwada Biomedical LLC, Covation Biomaterials, Starch Medical Inc.

North America was the largest region in the polymeric biomaterials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymeric biomaterials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the polymeric biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polymeric biomaterials market consists of sales of biomedical sensors and monitors, dental products, wound care products, medical devices and implants, and dressings and bandages. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.